Concepedia

Yoshihiro Nambu

YN

Statistics

Publications

28

Citations

2.6K

H-Index

21

Active since

1997

Affiliations

Kanazawa Medical University(Current)

National Cancer Center Hospital East

Eli Lilly (Japan)

Nippon Kayaku (Japan)

Kindai University

Yoshihiro Nambu is an author at Kanazawa Medical University specializing in medicine, pharmacology, and oncology.

Publications per year

1997–2019

28

Publications

28

Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan

Takuji Okusaka, Kohei Nakachi, Akira Fukutomi et al. · British Journal of Cancer · 2010 · 752 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.

Kotaro Higashi, Yoshimichi Ueda, Yukiko Arisaka et al. · PubMed · 2002 · 275 citations

Medicine, Oncology, Chemotherapy +16

Correlation of Glut-1 glucose transporter expression with [18F]FDG uptake in non-small cell lung cancer

Kotaro Higashi, Yoshimichi Ueda, Aya Sakurai et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2000 · 211 citations

Medicine, Cell Biology, Oncology +10

FDG PET measurement of the proliferative potential of non-small cell lung cancer.

Kotaro Higashi, Yoshimichi Ueda, Mizuki Yagishita et al. · PubMed · 2000 · 173 citations

Medicine, Nuclear Medicine, Oncology +17

Fas/APO-1 (CD95) is not translocated to the cell membrane in esophageal adenocarcinoma.

Steven J. Hughes, Yoshihiro Nambu, Oliver S. Soldes et al. · PubMed · 1997 · 135 citations

Medicine, Cell Biology, Pathology +17

1–5 of 28